| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 01/02/2013 | EP2539366A1 Protofibril-binding antibodies and their use in therapeutic and diagnostic methods for parkinson's disease, dementia with lewy bodies and other alpha-synucleinopathies |
| 01/02/2013 | EP2539365A2 Method of inducing the production of protective anti-hiv-1 antibodies |
| 01/02/2013 | EP2538981A1 Compositions and methods for the diagnosis and treatment of tumor |
| 01/02/2013 | EP2538976A1 Folate receptor 1 antibodies and immunoconjugates and uses thereof |
| 01/02/2013 | EP2538975A2 Immunoglobulin preparation and storage system for an immunoglobulin preparation |
| 01/02/2013 | CN1957256B Methods and compositions for the detection of cervical disease |
| 01/02/2013 | CN1854157B Antibodies to insulin-like growth factor i receptor |
| 01/02/2013 | CN1671416B Super humanized antibodies |
| 01/02/2013 | CN1454215B Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby |
| 01/02/2013 | CN102859360A Prognostic marker for cryoglobulinemic vasculitis and B cell malignancies in HCV infected patients |
| 01/02/2013 | CN102859001A Method for the selection of a long-term producing cell |
| 01/02/2013 | CN102858977A Antibody against serotype g lipopolysaccharide of pseudomonas aeruginosa |
| 01/02/2013 | CN102858976A Antibody against serotype b lipopolysaccharide of pseudomonas aeruginosa |
| 01/02/2013 | CN102858975A Antibody against serotype a lipopolysaccharide of pseudomonas aeruginosa |
| 01/02/2013 | CN102858974A Antibody against serotype e lipopolysaccharide of pseudomonas aeruginosa |
| 01/02/2013 | CN102858804A Neutralizing prolactin receptor antibodies and their therapeutic use |
| 01/02/2013 | CN102858803A Neutralizing prolactin receptor antibodies and their therapeutic use |
| 01/02/2013 | CN102858802A Human antigen binding proteins that bind beta-KLOTHO, FGF receptors and complexes thereof |
| 01/02/2013 | CN102858801A Neutralizing prolactin receptor antibodies and their therapeutic use |
| 01/02/2013 | CN102858800A Humanized antibodies |
| 01/02/2013 | CN102858799A Antibody against serotype i lipopolysaccharide of pseudomonas aeruginosa |
| 01/02/2013 | CN102858798A Methods for screening antibodies |
| 01/02/2013 | CN102858796A Oligomer-specific amyloid beta epitope and antibodies |
| 01/02/2013 | CN102858371A Antigen Binding Proteins Specific For Serum Amyloid P Component |
| 01/02/2013 | CN102858335A Use of ERBB3 inhibitors in the treatment of triple negative and basal-like breast cancers |
| 01/02/2013 | CN102850457A Autoimmune disease anti-autoantibody antibody and its preparation method and application |
| 01/02/2013 | CN102850456A Humanized monoclonal antibody of vascular endothelial growth factor as well as preparation method and application thereof |
| 01/02/2013 | CN102850455A Anti-glypican-3 antibody |
| 01/02/2013 | CN102850454A Anti-RSV (respiratory syncytial virus) human monoclonal antibody, and its preparation method |
| 01/02/2013 | CN102850453A Method for extracting and separating immunoglobulin IgY from egg yolk |
| 01/02/2013 | CN102850452A Compositions and methods for inhibiting endogenous immunoglobulin genes and producing transgenic human idiotype antibodies |
| 01/02/2013 | CN102847149A Methods of treating autoimmune and inflammatory diseases |
| 01/02/2013 | CN101903406B Bivalent, bispecific antibodies |
| 01/02/2013 | CN101899418B Avian influenza virus (AIV) as well as kit and vaccine used for detecting and preventing same |
| 01/02/2013 | CN101891805B Human enterovirus 71 type specific polypeptide and application thereof |
| 01/02/2013 | CN101858911B Method for simultaneously detecting antigen and antibody of infectious microorganism |
| 01/02/2013 | CN101824090B Monoclonal antibody hpam4 |
| 01/02/2013 | CN101799476B Reagent box for sieving autoantibody for tsh receptor |
| 01/02/2013 | CN101426812B Methods for altering protein production rates |
| 01/02/2013 | CN101103044B Anti-alhpha 9 integrin antibody and the use thereof |
| 01/01/2013 | USRE43899 Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents |
| 01/01/2013 | USRE43898 Altered antibodies and their preparation |
| 01/01/2013 | US8344115 Immunoassay for specific determination of S-adenosylmethionine and analogs thereof in biological samples |
| 01/01/2013 | US8344114 Antagonists of PCSK9 |
| 01/01/2013 | US8344113 Diagnostic tumor markers, drug screening for tumorigenesis inhibition, and compositions and methods for treatment of cancer |
| 01/01/2013 | US8344112 IGF-1R specific antibodies useful in the detection and diagnosis of cellular proliferative disorders |
| 01/01/2013 | US8344111 Human monoclonal nicotine specific antibodies |
| 01/01/2013 | US8344110 Antibodies to thymic stromal lymphopoietin (TSLP) receptor molecules and uses thereof |
| 01/01/2013 | US8344109 Anti-ricin antibody |
| 01/01/2013 | US8344105 Polypeptides having DNA polymerase activity |
| 01/01/2013 | US8344102 Nanoparticle and magnetic resonance imaging contrast agent |
| 01/01/2013 | US8344100 Poly-epitope peptide derived from thymidylate synthase having immunological and anti-tumour activity |
| 01/01/2013 | US8343761 Methods of generating and using antibody-producing cells |
| 01/01/2013 | US8343508 Botulinum antitoxin compositions and methods |
| 01/01/2013 | US8343503 Contiguous overlapping peptides for treatment of birch pollen allergy |
| 01/01/2013 | US8343500 Peptide composition |
| 01/01/2013 | US8343496 Anti-CD74 immunoconjugates and methods |
| 01/01/2013 | US8343494 Antibodies against LLG polypeptides of the triacylglycerol lipase family |
| 01/01/2013 | US8343493 Antibodies specific of the β-amyloid peptides and their uses as diagnostic agents or drugs |
| 01/01/2013 | US8343492 Method for blocking binding of CX3C chemokines using CX3C chemokine antibodies |
| 01/01/2013 | US8343490 Monoclonal antibody SC104 and derivative thereof specifically binding to a sialyltetraosyl carbohydrate as a potential anti-tumor therapeutic agent |
| 01/01/2013 | US8343489 Methods for humanizing antibodies and humanized antibodies made thereby |
| 12/27/2012 | WO2012178150A2 Methods for developing antigen-specific antibody-producing cell lines and monoclonal antibodies |
| 12/27/2012 | WO2012178137A1 Light chain immunoglobulin fusion proteins and methods of use thereof |
| 12/27/2012 | WO2012177788A1 Modulators of 4-1bb and immune responses |
| 12/27/2012 | WO2012176876A1 Method for producing protein preparation |
| 12/27/2012 | WO2012176779A1 Anti-erbb3 antibody |
| 12/27/2012 | WO2012176765A1 Anti-human p-cadherin (cdh3) recombinant antibody |
| 12/27/2012 | WO2012176158A1 Purification of chimeric protein |
| 12/27/2012 | WO2012175874A1 Use of a high-adcc anti-cd20 antibody for treating waldenström's macroglobulemia |
| 12/27/2012 | WO2012175751A2 Fc variants with reduced effector functions |
| 12/27/2012 | WO2012175741A2 Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domains |
| 12/27/2012 | WO2012175740A1 Immunoglobulin single variable domains directed against ige |
| 12/27/2012 | WO2012175692A1 Anti-axl antibodies and uses thereof |
| 12/27/2012 | WO2012175691A1 Anti-axl antibodies and uses thereof |
| 12/27/2012 | WO2012175643A2 Binding domains directed against gpcr:g protein complexes and uses derived thereof |
| 12/27/2012 | WO2012175576A1 Anti-cxcr4 antibody with effector functions and its use for the treatment of cancer. |
| 12/27/2012 | WO2012175508A1 Removal of target cells by circulating virus-specific cytotoxic t-cells using mhc class i comprising complexes |
| 12/27/2012 | WO2012175400A1 Serum albumin binding proteins |
| 12/27/2012 | WO2012175222A1 AN IL-15 AND IL-15Rα SUSHI DOMAIN BASED IMMUNOCYTOKINES |
| 12/27/2012 | WO2012145714A3 Prostate-specific membrane antigen binding proteins and related compositions and methods |
| 12/27/2012 | WO2012131555A3 Hetero-dimeric immunoglobulins |
| 12/27/2012 | WO2012128508A3 Binding molecules capable of neutralizing the rabies virus, and uses thereof |
| 12/27/2012 | WO2012125864A3 Overcoming resistance to erbb pathway inhibitors |
| 12/27/2012 | WO2012125573A3 Use of inhibitors of egfr-family receptors in the treatment of hormone refractory breast cancers |
| 12/27/2012 | WO2012122513A3 Generation of anti-fn14 monoclonal antibodies by ex-vivo accelerated antibody evolution |
| 12/27/2012 | WO2012012531A9 Compositions and methods featuring il-6 and il-21 antagonists |
| 12/27/2012 | US20120329997 Antibodies against human csf-1r and uses thereof |
| 12/27/2012 | US20120329996 Optimized Monoclonal Antibodies against Tissue Factor Pathway Inhibitor (TFPI) |
| 12/27/2012 | US20120329995 Novel Lowered Affinity Antibodies And Methods of Making the Same |
| 12/27/2012 | US20120329994 Production of a Monoclonal Antibody Therapeutic Against West Nile Virus in Plants |
| 12/27/2012 | US20120329990 B7-related nucleic acids and polypeptides useful for immunomodulation |
| 12/27/2012 | US20120329854 Methods and Compounds for the Diagnosis and Treatment for Cancer |
| 12/27/2012 | US20120329726 Hair Shape Susceptibility Gene |
| 12/27/2012 | US20120329709 Production of glycoproteins |
| 12/27/2012 | US20120329706 Hepatitis b virus pre-s1 derived synthetic polypeptides and uses thereof |
| 12/27/2012 | US20120329671 Methods of identifying obm modulators |
| 12/27/2012 | US20120329129 Magnetic nanoparticle with biocompatibility |
| 12/27/2012 | US20120329079 Pro108 Antibody Compositions and Methods of Use and Use of Pro108 to Assess Cancer Risk |
| 12/27/2012 | US20120329078 Method of diagnosing cancer using g-csf protein having a deletion of an amino acid sequence corresponding to exon 3 as a diagnostic cancer marker |